압력 및 접촉 작동식 안전 란셋 시장 규모, 점유율, 성장 및 세계 산업 분석 : 유형별, 용도별, 지역별 인사이트 및 예측(2024-2032년)

Growth Factors of pressure/contact-activated safety lancet Market

The global pressure/contact-activated safety lancet market is witnessing significant growth due to the increasing prevalence of diabetes, rising demand for minimally invasive blood sampling, and the shift toward home-based diagnostics. The market was valued at USD 414.9 million in 2024, is projected to reach USD 456.2 million in 2025, and is expected to expand to USD 933.0 million by 2032, representing a CAGR of 10.8% during the forecast period. North America dominated the global market in 2024 with a 42.35% share, driven by advanced healthcare infrastructure, high awareness, and extensive adoption of safe and easy-to-use lancets.

Pressure/contact-activated safety lancets are single-use, disposable devices designed for capillary blood sampling, particularly for diabetes management and other diagnostic applications. These devices feature automatic retraction, are activated by applying small pressure on the fingertip, and eliminate the need for manual triggering. The lancets provide reduced pain, minimal blood loss, and improved hygiene, making them highly suitable for home and clinical use.

Market Drivers

The primary driver of this market is the rising prevalence of diabetes worldwide. According to the International Diabetes Federation, around 589 million adults were living with diabetes globally in 2024, projected to increase to 853 million by 2050. Frequent self-monitoring of blood glucose (SMBG) drives demand for user-friendly lancets, as pressure/contact-activated devices ensure consistent penetration depth, reduce needlestick injuries, and simplify daily monitoring.

Another significant growth driver is the shift toward home healthcare monitoring. With rising chronic disease prevalence, patients prefer cost-effective, convenient self-monitoring solutions. Contact-activated lancets, which eliminate the need for button activation, are ideal for untrained users, including elderly and pediatric patients, facilitating home diagnostics and boosting market adoption.

Market Restraints

The growth of pressure/contact-activated lancets faces competition from button-activated safety lancets, which provide predictable penetration depth, ergonomic designs, and multi-depth adjustments. Button-activated models are increasingly preferred in clinical and home settings, limiting the adoption of pressure-activated devices. Additionally, limited accessibility in low- and middle-income countries, coupled with affordability challenges and inadequate healthcare infrastructure, restrains market growth, particularly in regions such as South Asia and parts of Africa.

Market Opportunities

Technological advancements, such as ultra-fine gauge needles (21G-30G) and spring-loaded mechanisms, offer nearly painless blood sampling and patient comfort. The growing adoption of minimally invasive, ergonomic designs and the shift toward home-based self-monitoring provide significant market opportunities. Rising awareness of safe blood sampling practices in emerging economies further enhances the potential for growth.

Segmentation Analysis

• By Incision Type: Needle lancets dominate due to safety, reduced pain, and ease of use, while blade lancets are expected to grow due to higher blood volume yield for neonatal and clinical testing.
• By Age Group: The adult segment holds the largest share due to extensive blood glucose, cholesterol, and hemoglobin testing. The pediatric segment is growing as children with Type 1 diabetes increasingly require self-monitoring.
• By Application: Blood glucose monitoring dominates the market, while hemoglobin testing is projected to grow fastest due to increasing HBA1C testing globally.
• By Gauge Size: Above 28G needles lead due to minimal pain, less trauma, and suitability for routine monitoring.
• By Distribution Channel: Hospital pharmacies currently dominate due to high patient footfall, while online pharmacies are growing fastest due to convenience and delivery benefits.

Regional Outlook

• North America: Dominated the market in 2024 with a market value of USD 175.7 million, driven by government reimbursements, advanced infrastructure, and high adoption rates.
• Europe: The second-largest market, benefiting from robust healthcare systems and spending on diagnostic tools.
• Asia Pacific: Expected to register the highest CAGR due to the high prevalence of diabetes in India, China, and Southeast Asia.
• Latin America & Middle East & Africa: Currently hold smaller shares but are witnessing gradual growth due to increased healthcare awareness and spending.

Competitive Landscape

Key players dominating the global market include BD, Cardinal Health, HTL-STREFA (MTD Medical Technology and Devices), Medline Industries, Owen Mumford, and Braun SE. Companies are focusing on product innovation, strategic collaborations, and geographic expansion to enhance market reach. For example, in January 2025, BD expanded its U.S. manufacturing network to meet growing demand, while Sterilance Medical showcased its latest products at MEDICA 2024.

In conclusion, the pressure/contact-activated safety lancet market is set to expand from USD 414.9 million in 2024 to USD 933.0 million by 2032, driven by rising diabetes prevalence, technological innovations, and the increasing trend toward home healthcare monitoring. As patient-friendly, minimally invasive, and safer lancet designs gain prominence, this market is poised for sustained growth globally.

Segmentation By Incision Type, Age Group, Application, Gauge Size, Distribution Channel, and Region

By Incision Type * Needle

• Blade

By Age Group * Adult

• Pediatric

By Application * Blood Glucose Monitoring

• Hemoglobin Testing
• Cholesterol Testing
• Others

By Gauge Size * 22G and Below

• 23G-28G
• Above 28G

By Distribution Channel * Hospital Pharmacies

• Retail Pharmacies
• Online Pharmacies/E-commerce Platforms

By Region * North America (By Incision Type, Age Group, Application, Gauge Size, Distribution Channel, and Country)

U.S.

Canada

• Europe (By Incision Type, Age Group, Application, Gauge Size, Distribution Channel, Country/Sub-Region)

Germany

U.K.

France

Italy

Spain

Scandinavia

Rest of Europe

• Asia Pacific (By Incision Type, Age Group, Application, Gauge Size, Distribution Channel, Country/Sub-Region)

China

Japan

India

Australia

Southeast Asia

Rest of Asia Pacific

• Latin America (By Incision Type, Age Group, Application, Gauge Size, Distribution Channel, Country/Sub-Region)

Brazil

Mexico

Rest of Latin America

• Middle East & Africa (By Incision Type, Age Group, Application, Gauge Size, Distribution Channel, Country/Sub-Region)

GCC

South Africa

Rest of the Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Prevalence of Diabetes - by Key Countries/Regions, 2024
• 4.2. Estimated Number of SMBG Users, By Key Countries/Region, 2024
• 4.3. Reimbursements Scenario
• 4.4. Pricing Analysis
• 4.5. Key Industry Developments (Mergers, Acquisitions, Partnership; etc.)

5. Global Pressure/Contact-activated Safety Lancet Market Analysis, Insights and Forecast, 2019-2032

• 5.1. Market Analysis, Insights and Forecast - By Incision Type
  • 5.1.1. Needle
  • 5.1.2. Blade
• 5.2. Market Analysis, Insights and Forecast - By Age Group
  • 5.2.1. Adult
  • 5.2.2. Pediatric
• 5.3. Market Analysis, Insights and Forecast - By Application
  • 5.3.1. Blood Glucose Monitoring
  • 5.3.2. Hemoglobin Testing
  • 5.3.3. Cholesterol Testing
  • 5.3.4. Others
• 5.4. Market Analysis, Insights and Forecast - By Gauge Size
  • 5.4.1. 22G and Below
  • 5.4.2. 23G-28G
  • 5.4.3. Above 28G
• 5.5. Market Analysis, Insights and Forecast - By Distribution Channel
  • 5.5.1. Hospital Pharmacies
  • 5.5.2. Retail Pharmacies
  • 5.5.3. Online Pharmacies/E-commerce Platforms
• 5.6. Market Analysis, Insights and Forecast - By Region
  • 5.6.1. North America
  • 5.6.2. Europe
  • 5.6.3. Asia Pacific
  • 5.6.4. Latin America
  • 5.6.5. Middle East & Africa

6. North America Pressure/Contact-activated Safety Lancet Market Analysis, Insights and Forecast, 2019-2032

• 6.1. Market Analysis, Insights and Forecast - By Incision Type
  • 6.1.1. Needle
  • 6.1.2. Blade
• 6.2. Market Analysis, Insights and Forecast - By Age Group
  • 6.2.1. Adult
  • 6.2.2. Pediatric
• 6.3. Market Analysis, Insights and Forecast - By Application
  • 6.3.1. Blood Glucose Monitoring
  • 6.3.2. Hemoglobin Testing
  • 6.3.3. Cholesterol Testing
  • 6.3.4. Others
• 6.4. Market Analysis, Insights and Forecast - By Gauge Size
  • 6.4.1. 22G and Below
  • 6.4.2. 23G-28G
  • 6.4.3. Above 28G
• 6.5. Market Analysis, Insights and Forecast - By Distribution Channel
  • 6.5.1. Hospital Pharmacies
  • 6.5.2. Retail Pharmacies
  • 6.5.3. Online Pharmacies/E-commerce Platforms
• 6.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 6.6.1. U.S.
  • 6.6.2. Canada

7. Europe Pressure/Contact-activated Safety Lancet Market Analysis, Insights and Forecast, 2019-2032

• 7.1. Market Analysis, Insights and Forecast - By Incision Type
  • 7.1.1. Needle
  • 7.1.2. Blade
• 7.2. Market Analysis, Insights and Forecast - By Age Group
  • 7.2.1. Adult
  • 7.2.2. Pediatric
• 7.3. Market Analysis, Insights and Forecast - By Application
  • 7.3.1. Blood Glucose Monitoring
  • 7.3.2. Hemoglobin Testing
  • 7.3.3. Cholesterol Testing
  • 7.3.4. Others
• 7.4. Market Analysis, Insights and Forecast - By Gauge Size
  • 7.4.1. 22G and Below
  • 7.4.2. 23G-28G
  • 7.4.3. Above 28G
• 7.5. Market Analysis, Insights and Forecast - By Distribution Channel
  • 7.5.1. Hospital Pharmacies
  • 7.5.2. Retail Pharmacies
  • 7.5.3. Online Pharmacies/E-commerce Platforms
• 7.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 7.6.1. U.K.
  • 7.6.2. Germany
  • 7.6.3. France
  • 7.6.4. Spain
  • 7.6.5. Italy
  • 7.6.6. Scandinavia
  • 7.6.7. Rest of Europe

8. Asia pacific Pressure/Contact-activated Safety Lancet Market Analysis, Insights and Forecast, 2019-2032

• 8.1. Market Analysis, Insights and Forecast - By Incision Type
  • 8.1.1. Needle
  • 8.1.2. Blade
• 8.2. Market Analysis, Insights and Forecast - By Age Group
  • 8.2.1. Adult
  • 8.2.2. Pediatric
• 8.3. Market Analysis, Insights and Forecast - By Application
  • 8.3.1. Blood Glucose Monitoring
  • 8.3.2. Hemoglobin Testing
  • 8.3.3. Cholesterol Testing
  • 8.3.4. Others
• 8.4. Market Analysis, Insights and Forecast - By Gauge Size
  • 8.4.1. 22G and Below
  • 8.4.2. 23G-28G
  • 8.4.3. Above 28G
• 8.5. Market Analysis, Insights and Forecast - By Distribution Channel
  • 8.5.1. Hospital Pharmacies
  • 8.5.2. Retail Pharmacies
  • 8.5.3. Online Pharmacies/E-commerce Platforms
• 8.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 8.6.1. Japan
  • 8.6.2. China
  • 8.6.3. India
  • 8.6.4. Australia
  • 8.6.5. Southeast Asia
  • 8.6.6. Rest of Asia Pacific

9. Latin America Pressure/Contact-activated Safety Lancet Market Analysis, Insights and Forecast, 2019-2032

• 9.1. Market Analysis, Insights and Forecast - By Incision Type
  • 9.1.1. Needle
  • 9.1.2. Blade
• 9.2. Market Analysis, Insights and Forecast - By Age Group
  • 9.2.1. Adult
  • 9.2.2. Pediatric
• 9.3. Market Analysis, Insights and Forecast - By Application
  • 9.3.1. Blood Glucose Monitoring
  • 9.3.2. Hemoglobin Testing
  • 9.3.3. Cholesterol Testing
  • 9.3.4. Others
• 9.4. Market Analysis, Insights and Forecast - By Gauge Size
  • 9.4.1. 22G and Below
  • 9.4.2. 23G-28G
  • 9.4.3. Above 28G
• 9.5. Market Analysis, Insights and Forecast - By Distribution Channel
  • 9.5.1. Hospital Pharmacies
  • 9.5.2. Retail Pharmacies
  • 9.5.3. Online Pharmacies/E-commerce Platforms
• 9.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 9.6.1. Brazil
  • 9.6.2. Mexico
  • 9.6.3. Rest of Latin America

10. Middle East & Africa Pressure/Contact-activated Safety Lancet Market Analysis, Insights and Forecast, 2019-2032

• 10.1. Market Analysis, Insights and Forecast - By Incision Type
  • 10.1.1. Needle
  • 10.1.2. Blade
• 10.2. Market Analysis, Insights and Forecast - By Age Group
  • 10.2.1. Adult
  • 10.2.2. Pediatric
• 10.3. Market Analysis, Insights and Forecast - By Application
  • 10.3.1. Blood Glucose Monitoring
  • 10.3.2. Hemoglobin Testing
  • 10.3.3. Cholesterol Testing
  • 10.3.4. Others
• 10.4. Market Analysis, Insights and Forecast - By Gauge Size
  • 10.4.1. 22G and Below
  • 10.4.2. 23G-28G
  • 10.4.3. Above 28G
• 10.5. Market Analysis, Insights and Forecast - By Distribution Channel
  • 10.5.1. Hospital Pharmacies
  • 10.5.2. Retail Pharmacies
  • 10.5.3. Online Pharmacies/E-commerce Platforms
• 10.6. Market Analysis, Insights and Forecast - By Country/Sub-region
  • 10.6.1. GCC
  • 10.6.2. South Africa
  • 10.6.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2024)
• 11.2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
  • 11.2.1. B. Braun SE
  • 11.2.2. Cardinal Health
  • 11.2.3. Greiner Bio-One International GmbH
  • 11.2.4. BD
  • 11.2.5. HTL-STREFA (MTD Medical Technology and Devices)
  • 11.2.6. Medline Industries, LP.
  • 11.2.7. Aeras Medical Pte Ltd.
  • 11.2.8. Owen Mumford